WASHINGTON, D.C. — March 25, 2026. U.S. lawmakers have launched a sweeping investigation into several Wall Street underwriters, including Dominari Securities, a firm with direct ties to the Trump family, for their alleged role in facilitating Chinese stock manipulation schemes that have drained approximately $16 billion from American investors since 2023. The House Select Committee on China, chaired by Representative John Moolenaar (R-MI) with Ranking Member Ro Khanna (D-CA), sent formal letters on Monday demanding documents from three brokerage firms that helped bring Chinese companies to U.S. markets through initial public offerings (IPOs) later tied to coordinated “ramp-and-dump” fraud. This probe represents one of the most significant congressional actions targeting financial intermediaries’ involvement with Chinese market manipulation, placing particular scrutiny on Dominari Securities due to its high-profile political connections.
Congressional Probe Targets Wall Street’s Chinese IPO Pipeline
The House Select Committee on China has formally requested extensive documentation from D. Boral Capital, Dominari Securities, and Revere Securities regarding their underwriting activities for Chinese companies listing on American exchanges. Lawmakers allege these firms “appear to facilitate” schemes where Chinese shell companies use U.S. IPOs to artificially inflate share prices through coordinated trading and promotional campaigns, then dump shares on unsuspecting retail investors before the stocks inevitably crash. The committee’s letters, obtained by financial journalists, state bluntly: “These scam centers defraud American households through coordinated ‘ramp-and-dump’ stock manipulation schemes involving Chinese shell companies listed on American exchanges.”
Investigators point to specific patterns where dozens of trading accounts placed nearly identical buy orders above IPO prices, temporarily pushing valuations higher before insiders sold their stakes. This systematic manipulation creates the illusion of market demand while concealing the coordinated nature of the buying. The Financial Industry Regulatory Authority (FINRA) had previously issued warnings about similar patterns, but the congressional investigation suggests these alerts went largely unheeded by some market participants. The requested documents include all communications, trading records, funding sources, and due diligence policies related to Chinese IPOs, with a submission deadline set for this Friday.
$16 Billion in Investor Losses and a 300% Surge in Complaints
The financial impact of these alleged manipulation schemes has reached staggering proportions. Lawmakers cite estimates that approximately $16 billion in U.S. investor wealth has evaporated since 2023 through these coordinated Chinese stock scams. Meanwhile, FBI data shows a 300% increase in complaints tied specifically to Chinese stock manipulation cases over the same period. This dramatic surge indicates both the scale of the problem and growing awareness among defrauded investors who are now reporting their losses to authorities.
- Retail Investor Devastation: Individual traders, often using popular retail platforms, have borne the brunt of losses when artificially inflated Chinese stocks suddenly collapse.
- Market Integrity Erosion: The schemes undermine confidence in U.S. capital markets as legitimate investment vehicles, potentially deterring future participation.
- Regulatory Challenge Escalation: The cross-border nature of these schemes complicates enforcement, requiring coordination between U.S. and Chinese authorities that has historically been difficult.
Financial Regulators and Experts Sound Alarm
Securities law experts have noted the investigation’s significance in targeting the financial intermediaries rather than just the foreign issuers. “This represents a strategic shift,” explains Dr. Evelyn Chen, a former SEC enforcement attorney now teaching at Georgetown University Law Center. “By focusing on the U.S. underwriters who facilitate access to American markets, lawmakers are attacking the supply chain of these frauds rather than just chasing individual bad actors overseas. The due diligence expectations for underwriters are clear, and if they’re being circumvented, that’s a serious breach of market gatekeeping functions.” The committee has specifically referenced previous FINRA alerts about similar patterns, suggesting regulators had identified red flags that may have been ignored.
Dominari Securities: Trump Family Connections Draw Intense Scrutiny
Among the three firms under investigation, Dominari Securities has attracted particular attention due to its conspicuous political connections. The brokerage operates from offices in New York’s Trump Tower and is owned by Dominari Holdings, where Eric Trump, son of former President Donald Trump, serves as the fourth-largest shareholder. Both Eric Trump and his brother Donald Trump Jr. joined the company’s advisory board in February 2025, bringing immediate name recognition and political capital to the firm. This timeline places their involvement beginning just as regulatory scrutiny of Chinese listings was intensifying.
| Firm Under Investigation | Key Connection | Relevant Chinese IPO Activity |
|---|---|---|
| Dominari Securities | Eric Trump (4th largest shareholder), Donald Trump Jr. (Advisory Board) | Multiple Chinese small-cap listings 2024-2025 |
| D. Boral Capital | Specializes in cross-border financings | Focus on technology and manufacturing IPOs |
| Revere Securities | Established market maker with international desk | Historically active in Asian market access |
Next Steps: Document Deadline and Potential Consequences
The immediate timeline requires all three firms to submit requested documents by Friday, March 28, 2026. Congressional staff will then review the materials to determine whether U.S. financial intermediaries “may have inadvertently helped facilitate manipulation schemes tied to Chinese issuers,” as stated in the committee letters. Depending on their findings, several outcomes remain possible: the committee could issue subpoenas for additional information, refer matters to the Securities and Exchange Commission (SEC) or Department of Justice for potential enforcement actions, or draft legislation tightening oversight of foreign listings.
Industry Reactions and Political Implications
Initial reactions from the financial industry have been cautious. Some compliance officers at major banks have privately expressed concern about heightened scrutiny of all cross-border transactions, while others welcome clearer standards. Politically, the bipartisan nature of the investigation—with Republican Chairman Moolenaar and Democratic Ranking Member Khanna jointly leading—suggests consensus about addressing Chinese market manipulation, though interpretations of the Trump family involvement may diverge along partisan lines as the probe develops. Market analysts note increased volatility in small-cap Chinese American Depositary Receipts (ADRs) following news of the investigation.
Conclusion
The congressional investigation into Trump-linked Dominari Securities and other underwriters represents a significant escalation in addressing Chinese stock manipulation schemes that have cost American investors billions. By targeting the financial intermediaries that provide market access, lawmakers are attempting to close a critical vulnerability in U.S. capital markets. The involvement of high-profile political figures ensures this probe will receive sustained attention, potentially driving reforms in how foreign companies, particularly from China, access American exchanges. Investors should monitor Friday’s document submission deadline and subsequent committee findings, which may signal broader regulatory changes affecting all international listings. The $16 billion question remains: how many gatekeepers failed in their due diligence, and what systemic fixes will emerge from this scrutiny?
Frequently Asked Questions
Q1: What exactly are lawmakers accusing Dominari Securities of doing?
Lawmakers allege Dominari Securities and two other firms helped underwrite Chinese IPOs that were later used in “ramp-and-dump” schemes. These involve artificially inflating stock prices through coordinated trading, then dumping shares on retail investors before prices collapse.
Q2: How much money have investors lost according to the investigation?
The House Select Committee cites estimates that approximately $16 billion in U.S. investor wealth has been drained since 2023 through these specific Chinese stock manipulation schemes.
Q3: What is the deadline for the firms to respond to Congress?
All three firms—Dominari Securities, D. Boral Capital, and Revere Securities—must submit requested documents by Friday, March 28, 2026.
Q4: Why is Dominari Securities getting special attention in news reports?
Dominari has direct ties to the Trump family: Eric Trump is the fourth-largest shareholder in its parent company, and both he and Donald Trump Jr. joined its advisory board in February 2025.
Q5: Have regulators warned about these problems before?
Yes. The congressional letters mention previous warnings by FINRA about similar patterns, suggesting regulatory alerts predated this investigation but may not have prompted sufficient action from some market participants.
Q6: How might this investigation affect ordinary investors in Chinese stocks?
Increased scrutiny may lead to more rigorous due diligence on foreign listings, potentially reducing fraud but possibly limiting access to some legitimate international investment opportunities. Investors should exercise heightened caution with small-cap Chinese ADRs.
